Avalo Therapeutics AVTX
NASDAQ AVTX
$12.32 -0.04 (-0.32%)
As of: Oct 21, 2026 · 2:47 PM EDT

Avalo Therapeutics (AVTX) Divestments (2019 - 2020)

Updated

Avalo Therapeutics (AVTX) reported Divestments of $12.84 million for FY2020, up 224.3% from $3.96 million in FY2019.

Analysis

Avalo Therapeutics (AVTX) Divestments (2019 - 2020) Analysis & Trends

  • According to Business Quant data, Divestments came in at $3.96 million in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Eli Lilly 1,136.92 Bn 1,105.50 Bn 19.71 Bn -
2 Johnson & Johnson 617.57 Bn 536.10 Bn 17.26 Bn -
3 AbbVie 501.37 Bn 474.48 Bn 12.70 Bn -
4 Merck 367.96 Bn 322.33 Bn 12.21 Bn -
5 Novartis Ag 297.98 Bn 261.97 Bn 11.24 Bn 62.00 Mn
6 Astrazeneca 261.45 Bn 235.14 Bn 12.86 Bn -
7 Amgen 236.30 Bn 191.70 Bn 7.24 Bn -
8 Gilead Sciences 190.27 Bn 164.46 Bn 6.22 Bn -
9 Pfizer 169.65 Bn 116.29 Bn 10.94 Bn -
10 Avalo Therapeutics 540.01 Mn -152.21 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 -12.84 Mn
Dec 31, 2019 3.96 Mn
API Access

Avalo Therapeutics Divestments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=divestments&ticker=AVTX&period=max&api_key=YOUR_API_KEY